Dietary lipids and environmental xenobiotics as risk factors for prostate cancer: The role of cytochrome P450

Pharmacological Reports : PR
Oksana Maksymchuk, Vladimir Kashuba

Abstract

Prostate cancer is one of the most common malignant neoplasms in men. Because of the increase in the number of cases as well as development of cancers resistant to conventional therapy, identification of the new molecular targets for the treatment and prevention is of great importance. For this purpose, many studies are aimed on revealing of molecular mechanisms of prostate cancer development. In this process, dietary lipids and environmental xenobiotics are largely involved and are considered as risk factors. A wide range of endogenous (cholesterol, polyunsaturated fatty acids, etc.) and exogenous (pollutants, drugs) compounds are metabolized in the human organism by cytochrome P450. From other hand, these compounds may alter cytochrome P450 expression levels, especially in prostate, which, in turn, affects cell metabolism. Cytochrome P450 is a member of signaling pathways, regulating cell cycle, apoptosis, invasion and adhesion. Hence, cytochrome P450 most probably plays the important role in initiation and progression of prostate cancer. Based on that, cytochrome P450 enzymes are considered as potential targets for the targeted therapy and prevention, and might serve as specific markers of malignant growth.

References

Oct 1, 1995·The Journal of Pathology·G I MurrayM D Burke
May 30, 2003·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Masuhiro NishimuraTetsuo Satoh
Jan 27, 2004·The American Journal of Pathology·Daotai NieKenneth V Honn
Jan 27, 2004·Journal of Cellular Biochemistry·Kenneth M Sterling, Kenneth R Cutroneo
Jan 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Dawn M CarnellSteven A Everett
Oct 21, 2004·Cancer·David G BostwickBarry Timms
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BidoliC La Vecchia
Sep 13, 2005·Biochemical and Biophysical Research Communications·Y Fujii-Kuriyama, J Mimura
Nov 14, 2006·Biochimica Et Biophysica Acta·Matej Seliskar, Damjana Rozman
Nov 28, 2006·Nature Reviews. Cancer·Daniel W Nebert, Timothy P Dalton
Jun 5, 2007·Bioorganic & Medicinal Chemistry·Robert D Bruno, Vincent C O Njar
Oct 5, 2007·Endocrine-related Cancer·S LeskeläC Rodríguez-Antona
Mar 12, 2009·Current Drug Metabolism·Beshay N M Zordoky, Ayman O S El-Kadi
Jul 16, 2010·Pharmacological Reports : PR·Cosima ArnoldWolf-Hagen Schunck
Jun 15, 2011·Molecular and Cellular Endocrinology·Srilatha SwamiDavid Feldman
Oct 22, 2011·Cancer Metastasis Reviews·Isabelle M BerquinYong Q Chen
May 9, 2012·Cancer Letters·Ketan GajjarFrancis L Martin
Jul 25, 2012·Current Opinion in Pharmacology·Kristine PeltonKeith R Solomon
Aug 10, 2012·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Oksana Maksymchuk, Mykola Chashchyn
Jun 14, 2013·BioMed Research International·Zhennan GuYong Q Chen
Aug 1, 2008·Future Lipidology·Kasem Nithipatikom, William B Campbell
May 14, 2014·Annual Review of Nutrition·David Bishop-BaileyCaroline Wheeler-Jones
Aug 4, 2015·Advances in Pharmacology·B WahlangRussell A Prough
Aug 4, 2015·Advances in Pharmacology·Eugene G Hrycay, Stelvio M Bandiera
Aug 4, 2015·Advances in Pharmacology·Chen Chen, Dao Wen Wang
Jun 18, 2016·Journal of Lipid Research·Tatiana Y HargroveGalina I Lepesheva
Jun 22, 2016·Cancer Research·Konrad H StopsackJennifer R Rider
Jul 22, 2016·International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition·Oksana MaksymchukOlexiy Moibenko
Aug 3, 2016·Therapeutic Advances in Medical Oncology·Anitha B AlexNeeraj Agarwal
Sep 21, 2016·Endocrine-related Cancer·Damien A LeachCharlotte L Bevan
Jan 29, 2017·Cancer Research·Mahmoud A AlfaqihStephen J Freedland
Oct 4, 2017·Current Cancer Drug Targets·Soraya Sajadimajd, Mozafar Khazaei

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Diane DownieG I Murray
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Meera KumarakulasinghamG I Murray
Journal of Biochemical and Molecular Toxicology
Leslie M Tompkins, Andrew D Wallace
© 2021 Meta ULC. All rights reserved